PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $296,000 | +24.9% | 5,000 | +108.3% | 0.00% | – |
| Q4 2017 | $237,000 | -69.5% | 2,400 | -63.1% | 0.00% | -100.0% |
| Q3 2017 | $778,000 | -48.2% | 6,500 | -62.2% | 0.00% | -50.0% |
| Q2 2017 | $1,503,000 | -89.9% | 17,200 | -72.7% | 0.00% | -87.5% |
| Q1 2015 | $14,875,000 | +24.6% | 63,000 | -0.1% | 0.02% | +33.3% |
| Q4 2014 | $11,936,000 | -24.9% | 63,064 | -5.4% | 0.01% | -25.0% |
| Q3 2014 | $15,904,000 | – | 66,664 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |